FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
10,781 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | Bamboo US Bidco LCC | ANDA | 83703-549 | 83703-0549-01 | — |
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | Bamboo US Bidco LCC | ANDA | 83703-550 | 83703-0550-01 | — |
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | Bamboo US Bidco LCC | ANDA | 83703-551 | 83703-0551-01 | — |
| Cyclophosphamide | Cyclophosphamide 500 mg/mL | InjectionIntravenous | Avyxa Pharma, LLC | NDA |
| 83831-116 |
| 83831-0116-01 |
| — |
| Cyclophosphamide | Cyclophosphamide 1 g/2mL | InjectionIntravenous | Avyxa Pharma, LLC | NDA | 83831-117 | 83831-0117-02 | — |
|---|
| Cyclophosphamide | Cyclophosphamide 2 g/4mL | InjectionIntravenous | Avyxa Pharma, LLC | NDA | 83831-118 | 83831-0118-04 | — |
|---|
| Cycloserine | Cycloserine 250 mg/1 | CapsuleOral | Dr. Reddys Laboratories, Inc. | ANDA | 43598-235 | 43598-0235-31 | — |
|---|
| Cyclosetbromocriptine mesylate | Bromocriptine mesylate .8 mg/1 | TabletOral | Avvisto Therapeutics LLC | NDA | 73515-123 | 73515-0123-2173515-0123-30 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/mL | SolutionOral | Teva Pharmaceuticals USA, Inc. | ANDA | 0172-7313 | 00172-7313-20 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Mylan Pharmaceuticals Inc. | ANDA | 0378-8760 | 00378-8760-5800378-8760-91 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Teva Pharmaceuticals, Inc. | ANDA | 0480-4076 | 00480-4076-3000480-4076-60 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | KVK-TECH, INC. | NDA authorized generic | 10702-808 | 10702-0808-0310702-0808-06 | — |
|---|
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-837 | 23155-0837-30 | — |
|---|
| Cyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-838 | 23155-0838-30 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-839 | 23155-0839-30 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Upsher-Smith Laboratories, LLC | ANDA | 24979-126 | 24979-0126-1824979-0126-19 | — |
|---|
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | ANDA | 59651-927 | 59651-0927-03 | — |
|---|
| Cyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | ANDA | 59651-928 | 59651-0928-65 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | ANDA | 59651-929 | 59651-0929-65 | — |
|---|
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Gelatin coatedOral | Apotex Corp. | ANDA | 60505-0133 | 60505-0133-00 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Gelatin coatedOral | Apotex Corp. | ANDA | 60505-0134 | 60505-0134-00 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Apotex Corp | NDA authorized generic | 60505-6202 | 60505-6202-0160505-6202-02 | — |
|---|
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Strides Pharma Science Limited | ANDA | 64380-127 | 64380-0127-02 | — |
|---|
| Cyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | Strides Pharma Science Limited | ANDA | 64380-128 | 64380-0128-02 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Strides Pharma Science Limited | ANDA | 64380-129 | 64380-0129-02 | — |
|---|
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Gelatin coatedOral | American Health Packaging | ANDA | 68084-879 | 68084-0879-25 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Gelatin coatedOral | American Health Packaging | ANDA | 68084-921 | 68084-0921-25 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Lupin Pharmaceuticals, Inc. | NDA authorized generic | 68180-214 | 68180-0214-3068180-0214-60 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Cipla USA Inc. | ANDA | 69097-292 | 69097-0292-0369097-0292-97 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Saptalis Pharmaceuticals, LLC | ANDA | 71656-012 | 71656-0012-3071656-0012-60 | — |
|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Devatis Inc. | ANDA | 73043-005 | 73043-0005-0173043-0005-02 | — |
|---|
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Dr. Reddy's Laboratories Inc | ANDA | 75907-047 | 75907-0047-30 | — |
|---|
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Dr. Reddy's Laboratories Inc | ANDA | 75907-048 | 75907-0048-30 | — |
|---|
| Cyclosporine Modifiedcyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Teva Pharmaceuticals USA, Inc. | ANDA | 0093-9018 | 00093-9018-65 | — |
|---|
| Cyclosporine Modifiedcyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | Teva Pharmaceuticals USA, Inc. | ANDA | 0093-9019 | 00093-9019-65 | — |
|---|
| Cyclosporine Modifiedcyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Teva Pharmaceuticals USA, Inc. | ANDA | 0093-9020 | 00093-9020-65 | — |
|---|
| CycloSPORINE, Modfiedcyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Apotex Corp. | ANDA | 60505-4630 | 60505-4630-03 | — |
|---|
| CycloSPORINE, Modfiedcyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | Apotex Corp. | ANDA | 60505-4631 | 60505-4631-03 | — |
|---|
| CycloSPORINE, Modfiedcyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Apotex Corp. | ANDA | 60505-4632 | 60505-4632-03 | — |
|---|
| Cyfendusanthrax vaccine adsorbed, adjuvanted | Bacillus anthracis strain v770-np1-r antigens 100 ug/mL | Injection, SuspensionIntramuscular | Emergent Product Development Gaithersburg Inc. | BLA | 71665-001 | 71665-0001-02 | — |
|---|
| Cyklokaprontranexamic acid | Tranexamic acid 100 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0013-1114 | 00013-1114-1500013-1114-21 | — |
|---|
| Cyltezoadalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0370 | 00597-0370-82 | — |
|---|
| Cyltezoadalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0375 | 00597-0375-97 | — |
|---|
| Cyltezoadalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0400 | 00597-0400-89 | — |
|---|
| Cyltezoadalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0405 | 00597-0405-80 | — |
|---|
| Cyltezoadalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0485 | 00597-0485-20 | — |
|---|
| Cyltezoadalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0495 | 00597-0495-50 | — |
|---|
| Cymbaltaduloxetine hydrochloride | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed releaseOral | Eli Lilly and Company | NDA | 0002-3235 | 00002-3235-60 | — |
|---|
| Cymbaltaduloxetine hydrochloride | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed releaseOral | Eli Lilly and Company | NDA | 0002-3240 | — | — |
|---|
| Cymbaltaduloxetine hydrochloride | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed releaseOral | Eli Lilly and Company | NDA | 0002-3270 | — | — |
|---|